Deal advances company’s intraoperative AlphaInformatiX platform and enhances the development of predictive analytics and AI-empowered surgical planning.
In approving OsteoDetect, FDA enumerated risks that are actually generic to diagnostic software.
Online ExclusivesWilliam A. Hyman, Professor Emeritus of Biomedical Engineering, Texas A&M University, & Adjunct Professor of Biomedical Engineering, The Cooper Union06.15.18